VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19

Original Article

Z. Cao, W. Gao, H. Bao, H. Feng, S. Mei, P. Chen, Y. Gao, Z. Cui, Q. Zhang, X. Meng, H. Gui, W. Wang, Y. Jiang, Z. Song, Y. Shi, J. Sun, Y. Zhang, Q. Xie, Y. Xu, G. Ning, Y. Gao, and R. Zhao

N Engl J Med 2023;388:406-417

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
02/01/2023
Course expires: 
02/02/2025
Take course

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Take course